P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas

Chimeric antigen receptor (CAR) T cell therapy has been proposed as a promising approach for treating glioblastoma. Here the authors show that p32 is expressed in murine and human glioma and that p32-directed CAR-T cells promote anti-tumor responses in preclinical models by targeting glioma cells an...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Liat Rousso-Noori, Ignacio Mastandrea, Shauli Talmor, Tova Waks, Anat Globerson Levin, Maarja Haugas, Tambet Teesalu, Luis Alvarez-Vallina, Zelig Eshhar, Dinorah Friedmann-Morvinski
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Q
Accès en ligne:https://doaj.org/article/c9d019d611994e5cb582be3f41cb6a8b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires